Lower Oxygen Concentration for Preventing Collapsed Lung

(RESPIRA-EIT Trial)

MS
Overseen ByMaximilian S Schaefer, M.D., PhD.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Beth Israel Deaconess Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether using less oxygen at the end of surgery can prevent a collapsed lung. Typically, patients receive 100% oxygen, but the study examines if 70% or 40% oxygen better prevents lung tissue from collapsing. It targets individuals undergoing planned surgeries with general anesthesia lasting 1 to 5 hours. Researchers will closely monitor participants' breathing and lung health during the trial. The goal is to discover a safer method for managing oxygen use during surgery. As an unphased trial, it allows participants to contribute to significant research that could enhance surgical safety for future patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this method of using lower oxygen concentration is safe for preventing collapsed lung?

Research has shown that using less oxygen during mechanical ventilation might be safer for the lungs. Studies have found that high oxygen levels can cause parts of the lung to collapse, a condition known as atelectasis. Reducing the oxygen concentration to 70% or 40% may lower this risk.

Previous research suggests that patients with healthy lungs rarely experience complications like a collapsed lung when ventilated. Additionally, using less oxygen generally does not increase the risk of other serious issues. In fact, lower oxygen levels might even reduce the risk of death compared to higher levels.

Overall, using 70% or 40% oxygen appears to be well-tolerated and may decrease certain risks associated with ventilation. It is important to note that both these levels are still higher than normal room air, which contains about 21% oxygen.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores using lower oxygen concentrations to prevent collapsed lungs, offering a potentially safer alternative to the standard practice of using 100% oxygen. By ventilating patients with 40% or 70% oxygen before extubation, this approach might reduce the risk of lung damage associated with high oxygen levels. Current treatments often rely on high oxygen concentrations, which can be harsh on the lungs, so this method could lead to improved patient outcomes with fewer side effects.

What evidence suggests that using lower oxygen concentrations could be effective in preventing collapsed lung during anesthesia?

Studies have shown that using excessive oxygen during anesthesia can cause atelectasis, where part of the lung collapses. This occurs because the lungs take in too much oxygen, leading to deflation. In this trial, participants in the intervention group will receive ventilation with lower oxygen concentrations (either 40% or 70%) during the washout phase before extubation. Research suggests that reducing oxygen levels might lower the risk of atelectasis. Although data on these exact percentages is limited, this approach is based on existing knowledge of lung function. The goal is to keep the lungs open and functioning well without excessive oxygen.16789

Are You a Good Fit for This Trial?

This trial is for adults over 18 who are having elective surgery with general anesthesia and endotracheal intubation, lasting between 1-5 hours. They must consent to participate in the study.

Inclusion Criteria

I have given my consent to participate.
I am scheduled for a surgery that requires being put to sleep and a breathing tube.
My surgery is expected to last between 1 to 5 hours.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 day
1 visit (in-person)

Intervention

Participants are randomly assigned to receive either 70% or 100% oxygen concentration during the washout phase before extubation. EIT measurements and other parameters are recorded.

1 day
1 visit (in-person)

Postoperative Monitoring

Participants are monitored in the PACU for 60 minutes post-extubation, with EIT measurements and SpO2 levels recorded.

1-2 hours
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including re-intubation or non-invasive ventilation needs within 7 days.

7 days

What Are the Treatments Tested in This Trial?

Interventions

  • Ventilating the patient with 70% oxygen concentration
Trial Overview The study tests if using a lower oxygen concentration (70%) before removing a patient's breathing tube reduces lung collapse compared to the standard high oxygen level (100%). Patients are randomly assigned to one of these two approaches.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Intervention groupActive Control1 Intervention
Group II: Control groupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Beth Israel Deaconess Medical Center

Lead Sponsor

Trials
872
Recruited
12,930,000+

Published Research Related to This Trial

Oxygen therapy is crucial in emergency medicine and intensive care, but excessive use can lead to increased risks, such as the formation of harmful reactive-oxygen species, which may worsen patient outcomes.
While oxygen is essential to prevent hypoxemia, particularly in conditions like cardiac arrest and carbon monoxide poisoning, a normoxic oxygenation strategy is recommended to avoid the dangers of hyperoxia, especially in patients with chronic obstructive lung disease and myocardial infarction.
[Oxygen therapy in emergency and intensive care medicine].Grensemann, J., Wachs, C., Kluge, S.[2021]
A controlled oxygen delivery system using a 300 ml mask with a flow rate of 30 liters per minute can effectively provide the necessary inspired oxygen concentration of about 60% for patients with severe pulmonary function disturbances.
This system ensures that the oxygen concentration remains stable and does not fluctuate with the patient's breathing patterns, which is crucial for managing arterial hypoxaemia.
Controlled oxygen therapy at 60% concentration. Why and how.Campbell, EJ., Minty, KB.[2019]
Oxygen therapy is crucial in treating hypoxemia in acute care, but excessive oxygen supplementation can lead to harmful effects, known as hyperoxemia.
The article emphasizes the importance of following current recommendations for safe oxygen supplementation to avoid the negative consequences associated with too much oxygen.
[Oxygen toxicity in acute care settings].Lévy, C., Schmit, A., Younossian, AB., et al.[2019]

Citations

Iatrogenic pneumothorax related to mechanical ventilationIt has been reported that a 14%-87% incidence of pneumothorax occurs depending on severity and duration of ARDS and mode of ventilator for management[1,21,26].
Oxygenation target in acute respiratory distress syndromeThe findings from this literature review suggest that PaO 2 values ranging between 80 mmHg and 90 mmHg are acceptable in patients with ARDS.
Mechanical Ventilation - StatPearls - NCBI BookshelfMechanical ventilation is a critical intervention to sustain life in acute or emergent settings, particularly in patients with compromised airways.
Pneumothorax in patients with respiratory failure in ICUImplementation of lung protective ventilation has resulted in a significant decrease in pneumothorax incidence when compared to the pre lung protective ...
Lung Protective Ventilation in the ORIn this article, we discuss the various opinions and approaches to preventing lung collapse during general anesthesia.
Oxygen Targets During Mechanical Ventilation in the ICUThis systematic review and meta-analysis identified possible increased mortality with liberal oxygen targeting strategies and no difference in morbidity.
Guide to Lung-Protective Ventilation in Cardiac PatientsLung-protective ventilation (LPV) minimizes the risk of further lung injury through ventilator-induced lung injury.
Mechanical Ventilation: State of the ArtThis state-of-the-art review provides an update on the basic physiology of respiratory mechanics, the working principles, and the main ventilatory settings.
Ventilator-associated Event (VAE)Introduction. Mechanical ventilation is an essential, life-saving therapy for patients with critical illness and respiratory failure.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security